- New FirstLine TM facility in Middletown, DE will be the first in the United States
- Approx. 120 Jobs will be created with a focus on local community
- US health care customers welcome the new state-of-the-art manufacturing site
Datwyler, a leading supplier of customized sealing solutions to global manufacturers and companies,which operate in the health care and automotive industry, as well as the market segments civil engineering and consumer goods, today hosted a ground-breaking event for the first FirstLine TM facility in the US. With the beginning of this construction, Datwyler further expands its presence and resources in the largest pharma market worldwide. Torsten Maschke, CEO of Datwyler Sealing Solutions, personally opened the ground-breaking celebrations
Strengthening its position in the US, Datwyler has just announced a major investment of more than USD 100 million into a new FirstLine TM facility in Middletown, Delaware. FirstLine TM is Datwyler’s most advanced state-of-the-art manufacturing concept for high-quality elastomer components for fast growing injectable drug delivery systems, catering to the global health care industry. Production is scheduled to start in the first half of 2018 and the plant will be fully operational by the end of 2018. The US health care customers have already welcomed this new manufacturing site, which will enable Datwyler to provide locally produced components in highest quality in this key market.
Ceremony was hosted by Datwyler Sealing Solutions’ CEO and local officials
The event was formally opened by Torsten Maschke, CEO of Datwyler Sealing Solutions, and David Clark, Vice President of Operations America, who each held a speech to introduce Datwyler’s strategy for the US market and present the construction plans for the new facility in Middletown, Delaware. Bernice Whaley, Director of the Delaware Economic Development Office (DEDO), and Ken Branner Jr., Mayor of Middletown, held speeches illustrating the respective benefits Middletown and Datwyler will receive from the construction of the FirstLine TM facility – much focusing on the approximately 120 jobs that will have been created by the time the plant is fully operational at the end of 2018.
FirstLine standards for high-quality elastomer components
The FirstLine standards comprise a manufacturing concept for high-quality elastomer components based on ultra-modern clean room technology, automated production cells, fully automated camera inspection and a unique washing process. The FirstLine TM facilities are specially designed to manufacture pharmaceutical rubber components in a fully integrated good manufacturing practice (GMP) environment conforming to the highest industry standards. This innovative approach to manufacturing exceeds the most stringent quality standards of the European and US regulatory authorities and is certified to ISO 15378. The most complex rubber components produced at the FirstLine TM site belong to the Omniflex ® family of vial and syringe components, which prevent any interaction with the drugs due to their total fluoropolymer coating. These components are exclusively manufactured at the FirstLine TM sites.